Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Downgrade
Icade downgraded to Equal Weight from Overweight at Morgan Stanley » 05:58
11/24/22
11/24
05:58
11/24/22
05:58
CDMGF

Icade

$42.42 /

+ (+0.00%)

Morgan Stanley analyst…

Morgan Stanley analyst Bart Gysens downgraded Icade to Equal Weight from Overweight with a EUR 40 price target. The analyst adjusted his European real estate recommendations to position for a recessionary environment. Leverage remains the main variable for deciding where there is value in the sector, writes Gysens. U.K. remains his preferred region and the analyst is becoming "selectively more supportive" on German residential landlords.

ShowHide Related Items >><<
CDMGF Icade
$42.42 /

+ (+0.00%)

11/03/22 Citi
Icade downgraded to Sell from Neutral at Citi
10/11/22 Goldman Sachs
Icade downgraded to Sell from Neutral at Goldman Sachs
09/26/22 Exane BNP Paribas
Icade downgraded to Neutral from Outperform at Exane BNP Paribas
09/16/22 JPMorgan
Icade price target lowered to EUR 55 from EUR 70 at JPMorgan
Over a month ago
Downgrade
Icade downgraded to Sell from Neutral at Citi » 04:58
11/03/22
11/03
04:58
11/03/22
04:58
CDMGF

Icade

$35.50 /

+ (+0.00%)

Citi analyst Aakanksha…

Citi analyst Aakanksha Anand downgraded Icade to Sell from Neutral with a EUR 21.30 price target. The analyst sees potential for further downside in a recessionary scenario and expects refinancing costs to weigh on the company's earnings growth.

ShowHide Related Items >><<
CDMGF Icade
$35.50 /

+ (+0.00%)

10/11/22 Goldman Sachs
Icade downgraded to Sell from Neutral at Goldman Sachs
09/26/22 Exane BNP Paribas
Icade downgraded to Neutral from Outperform at Exane BNP Paribas
09/16/22 JPMorgan
Icade price target lowered to EUR 55 from EUR 70 at JPMorgan
08/15/22 UBS
Icade price target lowered to EUR 60 from EUR 75 at UBS
Downgrade
Icade downgraded to Sell from Neutral at Goldman Sachs » 17:49
10/11/22
10/11
17:49
10/11/22
17:49
CDMGF

Icade

$36.37 /

+ (+0.00%)

Goldman Sachs analyst…

Goldman Sachs analyst Jonathan Kownator downgraded Icade to Sell from Neutral with a price target of EUR 32.50, down from EUR 43.40. The stock has outperformed his coverage over the last three months by about 4% and has broadly performed in line year-to-date, but he also sees risks ahead of the company given its exposure to offices in higher vacancy areas, to homebuilding, and its higher leverage vs. peers, the analyst tells investors in a research note.

ShowHide Related Items >><<
CDMGF Icade
$36.37 /

+ (+0.00%)

09/26/22 Exane BNP Paribas
Icade downgraded to Neutral from Outperform at Exane BNP Paribas
09/16/22 JPMorgan
Icade price target lowered to EUR 55 from EUR 70 at JPMorgan
08/15/22 UBS
Icade price target lowered to EUR 60 from EUR 75 at UBS
08/05/22 Barclays
Icade price target lowered to EUR 61 from EUR 65 at Barclays
Downgrade
Icade downgraded to Neutral from Outperform at Exane BNP Paribas » 05:22
09/26/22
09/26
05:22
09/26/22
05:22
CDMGF

Icade

$38.00 /

-6.025 (-13.69%)

Exane BNP Paribas analyst…

Exane BNP Paribas analyst Alvaro Soriano downgraded Icade to Neutral from Outperform with a EUR 41 price target.

ShowHide Related Items >><<
CDMGF Icade
$38.00 /

-6.025 (-13.69%)

09/16/22 JPMorgan
Icade price target lowered to EUR 55 from EUR 70 at JPMorgan
08/15/22 UBS
Icade price target lowered to EUR 60 from EUR 75 at UBS
08/05/22 Barclays
Icade price target lowered to EUR 61 from EUR 65 at Barclays
07/05/22 Barclays
Icade price target lowered to EUR 65 from EUR 70 at Barclays
Recommendations
Icade price target lowered to EUR 55 from EUR 70 at JPMorgan » 11:39
09/16/22
09/16
11:39
09/16/22
11:39
CDMGF

Icade

$44.03 /

+ (+0.00%)

JPMorgan analyst Tim…

JPMorgan analyst Tim Leckie lowered the firm's price target on Icade to EUR 55 from EUR 70 and keeps a Neutral rating on the shares.

ShowHide Related Items >><<
CDMGF Icade
$44.03 /

+ (+0.00%)

08/15/22 UBS
Icade price target lowered to EUR 60 from EUR 75 at UBS
08/05/22 Barclays
Icade price target lowered to EUR 61 from EUR 65 at Barclays
07/05/22 Barclays
Icade price target lowered to EUR 65 from EUR 70 at Barclays
06/17/22 Societe Generale
Icade price target lowered to EUR 68.50 from EUR 81.50 at Societe Generale
Over a quarter ago
Recommendations
Icade price target lowered to EUR 60 from EUR 75 at UBS » 14:41
08/15/22
08/15
14:41
08/15/22
14:41
CDMGF

Icade

$48.93 /

+ (+0.00%)

UBS analyst Charles…

UBS analyst Charles Boissier lowered the firm's price target on Icade to EUR 60 from EUR 75 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
CDMGF Icade
$48.93 /

+ (+0.00%)

08/05/22 Barclays
Icade price target lowered to EUR 61 from EUR 65 at Barclays
07/05/22 Barclays
Icade price target lowered to EUR 65 from EUR 70 at Barclays
06/17/22 Societe Generale
Icade price target lowered to EUR 68.50 from EUR 81.50 at Societe Generale
06/14/22 Deutsche Bank
Icade price target lowered to EUR 50 from EUR 74 at Deutsche Bank
Recommendations
Icade price target lowered to EUR 61 from EUR 65 at Barclays » 11:08
08/05/22
08/05
11:08
08/05/22
11:08
CDMGF

Icade

$48.00 /

+ (+0.00%)

Barclays analyst Celine…

Barclays analyst Celine Huynh lowered the firm's price target on Icade to EUR 61 from EUR 65 and keeps an Overweight rating on the shares.

ShowHide Related Items >><<
CDMGF Icade
$48.00 /

+ (+0.00%)

07/05/22 Barclays
Icade price target lowered to EUR 65 from EUR 70 at Barclays
06/17/22 Societe Generale
Icade price target lowered to EUR 68.50 from EUR 81.50 at Societe Generale
06/14/22 Deutsche Bank
Icade price target lowered to EUR 50 from EUR 74 at Deutsche Bank
04/05/22 Citi
Icade price target lowered to EUR 64.20 at Citi
Recommendations
Icade price target lowered to EUR 65 from EUR 70 at Barclays » 13:00
07/05/22
07/05
13:00
07/05/22
13:00
CDMGF

Icade

$48.00 /

+ (+0.00%)

Barclays analyst Celine…

Barclays analyst Celine Huynh lowered the firm's price target on Icade to EUR 65 from EUR 70 and keeps an Overweight rating on the shares.

ShowHide Related Items >><<
CDMGF Icade
$48.00 /

+ (+0.00%)

06/17/22 Societe Generale
Icade price target lowered to EUR 68.50 from EUR 81.50 at Societe Generale
06/14/22 Deutsche Bank
Icade price target lowered to EUR 50 from EUR 74 at Deutsche Bank
04/05/22 Citi
Icade price target lowered to EUR 64.20 at Citi
03/28/22 Morgan Stanley
Icade price target lowered to EUR 68 from EUR 78 at Morgan Stanley
Recommendations
Icade price target lowered to EUR 68.50 from EUR 81.50 at Societe Generale » 13:45
06/17/22
06/17
13:45
06/17/22
13:45
CDMGF

Icade

$48.00 /

-10.16 (-17.47%)

Societe Generale analyst…

Societe Generale analyst Ben Richford lowered the firm's price target on Icade to EUR 68.50 from EUR 81.50 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
CDMGF Icade
$48.00 /

-10.16 (-17.47%)

06/14/22 Deutsche Bank
Icade price target lowered to EUR 50 from EUR 74 at Deutsche Bank
04/05/22 Citi
Icade price target lowered to EUR 64.20 at Citi
03/28/22 Morgan Stanley
Icade price target lowered to EUR 68 from EUR 78 at Morgan Stanley
03/10/22 Barclays
Icade upgraded to Overweight from Underweight at Barclays
Recommendations
Icade price target lowered to EUR 50 from EUR 74 at Deutsche Bank » 15:48
06/14/22
06/14
15:48
06/14/22
15:48
CDMGF

Icade

$58.16 /

+ (+0.00%)

Deutsche Bank analyst…

Deutsche Bank analyst Michael Kuhn lowered the firm's price target on Icade to EUR 50 from EUR 74 and keeps a Hold rating on the shares.

ShowHide Related Items >><<
CDMGF Icade
$58.16 /

+ (+0.00%)

04/05/22 Citi
Icade price target lowered to EUR 64.20 at Citi
03/28/22 Morgan Stanley
Icade price target lowered to EUR 68 from EUR 78 at Morgan Stanley
03/10/22 Barclays
Icade upgraded to Overweight from Underweight at Barclays
02/09/22 Oddo BHF
Icade downgraded to Underperform from Outperform at Oddo BHF

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.